Log In
BCIQ
Print this Print this
 

AXT914

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionOrally-active parathyroid hormone-releasing drug
Molecular Target Parathyroid hormone (PTH)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationOsteoporosis
Indication DetailsTreat osteoporosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today